The proteome of mesenteric lymph during acute pancreatitis and implications for treatment

JOP. 2009 Mar 9;10(2):130-42.

Abstract

Context: The protein fraction of mesenteric lymph during acute pancreatitis and other critical illness is thought to contain toxic factors. However, we do not have a complete description of the mesenteric lymph proteome during acute pancreatitis.

Objective: The aim of this study was to define the proteomic changes in mesenteric lymph during acute pancreatitis.

Setting: Animal Laboratory, University of Auckland, New Zealand.

Design: Mesenteric lymph was collected from sixteen male Wistar rats randomised to Group 1 (n=8) with taurocholate induced acute pancreatitis and Group 2 (n=8) sham control. The lymph was subjected to proteomic analysis using iTRAQ (Applied Biosystems, Foster City, CA, USA) and liquid chromatography-tandem mass spectrometry.

Results: Two hundred and forty-five proteins including 35 hypothetical proteins were identified in mesenteric lymph. Eight of the 245 proteins had a significant increase in their relative abundance in acute pancreatitis conditioned mesenteric lymph, and 7 of these were pancreatic catabolic enzymes (pancreatic amylase 2, pancreatic lipase, carboxypeptidase A2, chymotrypsinogen B, carboxypeptidase B1, cationic trypsinogen, ribonuclease 1).

Conclusions: This is the first comprehensive description of the proteome of mesenteric lymph during acute pancreatitis and has demonstrated a significantly increased relative abundance of 7 secreted pancreatic catabolic enzymes in acute pancreatitis conditioned mesenteric lymph. This study provides a clear rationale for further research to investigate the efficacy of enteral protease inhibitors in the treatment of acute pancreatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Chromatography, Liquid / methods
  • Databases, Protein
  • Lymph / metabolism*
  • Male
  • Mesentery
  • Pancreatitis / chemically induced
  • Pancreatitis / metabolism*
  • Pancreatitis / therapy
  • Proteome / analysis*
  • Proteomics / methods*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Taurocholic Acid

Substances

  • Proteome
  • Taurocholic Acid